Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Non-Current Debt (2020 - 2025)

Rapid Micro Biosystems' Non-Current Debt history spans 3 years, with the latest figure at $18.8 million for Q3 2025.

  • For Q3 2025, Non-Current Debt changed N/A year-over-year to $18.8 million; the TTM value through Sep 2025 reached $18.8 million, changed N/A, while the annual FY2020 figure was $24.8 million, N/A changed from the prior year.
  • Non-Current Debt for Q3 2025 was $18.8 million at Rapid Micro Biosystems, down from $25.0 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $25.0 million in Q2 2021 and bottomed at $18.8 million in Q3 2025.